[go: up one dir, main page]

WO2006018814A3 - Suspensions liquides orales de métaxalone - Google Patents

Suspensions liquides orales de métaxalone Download PDF

Info

Publication number
WO2006018814A3
WO2006018814A3 PCT/IB2005/052705 IB2005052705W WO2006018814A3 WO 2006018814 A3 WO2006018814 A3 WO 2006018814A3 IB 2005052705 W IB2005052705 W IB 2005052705W WO 2006018814 A3 WO2006018814 A3 WO 2006018814A3
Authority
WO
WIPO (PCT)
Prior art keywords
metaxalone
oral liquid
liquid suspensions
suspensions
processes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/IB2005/052705
Other languages
English (en)
Other versions
WO2006018814A2 (fr
Inventor
Ajay Kumar Singla
Malluru Subba Rao
Tausif Monif
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ranbaxy Laboratories Ltd
Original Assignee
Ranbaxy Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ranbaxy Laboratories Ltd filed Critical Ranbaxy Laboratories Ltd
Publication of WO2006018814A2 publication Critical patent/WO2006018814A2/fr
Publication of WO2006018814A3 publication Critical patent/WO2006018814A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)

Abstract

Formes galéniques de suspensions liquides orales de métaxalone et procédés de préparation desdites formes galéniques.
PCT/IB2005/052705 2004-08-16 2005-08-16 Suspensions liquides orales de métaxalone Ceased WO2006018814A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN1509DE2004 2004-08-16
IN1509/DEL/2004 2004-08-16

Publications (2)

Publication Number Publication Date
WO2006018814A2 WO2006018814A2 (fr) 2006-02-23
WO2006018814A3 true WO2006018814A3 (fr) 2006-08-24

Family

ID=35636902

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2005/052705 Ceased WO2006018814A2 (fr) 2004-08-16 2005-08-16 Suspensions liquides orales de métaxalone

Country Status (1)

Country Link
WO (1) WO2006018814A2 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011031176A1 (fr) * 2009-09-10 2011-03-17 Bial - Portela & C.A., S.A. Formulations de suspension orales d’acétate d’eslicarbazépine
IT1401086B1 (it) * 2010-07-19 2013-07-12 Farmalip S R L Dolcificante.
PT2663294E (pt) 2011-01-11 2016-01-25 Capsugel Belgium Nv Novas cápsulas duras contendo pululano
ITUB20155193A1 (it) * 2015-11-03 2017-05-03 Italfarmaco Spa Sospensioni orali di Givinostat fisicamente e chimicamente stabili
EP3509592A4 (fr) 2016-09-09 2020-07-22 Cutispharma, Inc. Suspensions et diluants pour le métronidazole et le baclofène
CN110678170A (zh) 2017-04-14 2020-01-10 比利时胶囊公司 普鲁兰多糖胶囊
CA3059529A1 (fr) 2017-04-14 2018-10-18 Capsugel Belgium Nv Procede de fabrication de pullulane

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3993767A (en) * 1975-11-18 1976-11-23 A. H. Robins Company, Incorporated Compositions to suppress gastric bleeding in indomethacin and phenylbutazone therapy
US20030236236A1 (en) * 1999-06-30 2003-12-25 Feng-Jing Chen Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs
WO2004066981A1 (fr) * 2003-01-29 2004-08-12 Sun Pharmaceutical Industries Limited Composition pharmaceutique orale a liberation controlee contenant du metaxalone en tant qu'agent actif
WO2005016310A1 (fr) * 2003-08-08 2005-02-24 Elan Pharma International Ltd. Nouvelles compositions de metaxalone

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3993767A (en) * 1975-11-18 1976-11-23 A. H. Robins Company, Incorporated Compositions to suppress gastric bleeding in indomethacin and phenylbutazone therapy
US20030236236A1 (en) * 1999-06-30 2003-12-25 Feng-Jing Chen Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs
WO2004066981A1 (fr) * 2003-01-29 2004-08-12 Sun Pharmaceutical Industries Limited Composition pharmaceutique orale a liberation controlee contenant du metaxalone en tant qu'agent actif
WO2005016310A1 (fr) * 2003-08-08 2005-02-24 Elan Pharma International Ltd. Nouvelles compositions de metaxalone

Also Published As

Publication number Publication date
WO2006018814A2 (fr) 2006-02-23

Similar Documents

Publication Publication Date Title
WO2006124748A3 (fr) Composes polycycliques et procedes pour les utiliser
WO2006131591A3 (fr) Forme posologique destinee a etre administree par voie orale
IL178730A0 (en) New pharmaceutical compositions for the treatment of sexual disorders ii
EP2213684A3 (fr) Anticorps nogo-a pour le traitement de la maladie d'Alzheimer
AP2334A (en) Novel heterocyclic compounds useful for the treatment of inflamatory and allergic disorders.
IL191283A (en) Compositions for treating eye irregularities
EP1893216A4 (fr) Methodes et preparations pour le traitement de troubles oculaires
WO2007056221A3 (fr) Aminopyrimidines utiles en tant qu'inhibiteurs de kinases
WO2008116139A3 (fr) Composés utiles en tant qu'inhibiteurs des kinases de janus
WO2008076392A3 (fr) Composés utilisables en tant qu'inhibiteurs de protéines kinases
IL176486A0 (en) Azabenzofuran substituted thioureas as inhibtitors of viral replication
ZA200606804B (en) Pharmaceutical composition for treatment of immunological disorders
WO2006015035A8 (fr) Composés utiles pour l'infection par hpv
WO2008079521A3 (fr) Composés hétéroaryle tricycliques utiles en tant qu'inhibiteurs de la janus kinase
ZA200801667B (en) Novel pharmaceutical combinations for the treatment of respiratory disorders
ZA200800926B (en) Oral suspension of prednisolone acetate
ZA200702523B (en) Process for the purification of 1,4-butanediol
TWI350757B (en) Aqueous suspensions of ciclesonide for nebulisation
WO2006018814A3 (fr) Suspensions liquides orales de métaxalone
EP1814535A4 (fr) Composes nitroses et nitrosyles, compositions et procedes destines au traitement de troubles ophtalmiques
WO2007025146A3 (fr) Preparations de balsalazide, leur procede d'obtention et leurs utilisations
SI1737820T1 (sl) Postopek asimetricne hidrogenacije, uporaben pri pripravi cikloalkanoidolnih derivatov
WO2006135694A3 (fr) Composes modulateurs d'uii et utilisation
MX2007006018A (es) Suspension farmaceutica oral novedosa de cristal de cefdinir.
WO2007144699A3 (fr) Procédé pour la préparation d'alfuzosine

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU LV MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase